Skip to main content

Table 2 Univariate and multivariate analyses for the relapse-free survival of patients with ICC

From: Risk stratification system to predict recurrence of intrahepatic cholangiocarcinoma after hepatic resection

Variables

n (%)

Relapse-free survival (%)

Univariate analysis

Multivariate analysis

1-year

3-year

5-year

HR (95% CI)

P value

HR (95% CI)

P value

Age

 > 60 years

50 (47.2)

36.0

15.6

11.6

1.302 (0.827-2.049)

0.253

NA

NA

 ≤ 60 years

56 (52.8)

42.9

25.0

9.8

    

Gender

 Male

62 (58.5)

38.7

17.0

10.0

1.129 (0.711-1.793)

0.608

NA

NA

 Female

44 (41.5)

40.9

25.0

11.8

    

HBV infection

 HBsAg

  Present

30 (28.2)

63.3

44.0

25.0

0.424 (0.239-0.751)

0.002

0.505 (0.279-0.914)

0.024

  Absent

76 (71.8)

30.3

11.8

6.3

    

HBsAg-negative

HBcAb-positive

 Present

12 (11.3)

41.7

0

0

0.734 (0.348-1.549)

0.415

NA

NA

 Absent

94 (88.7)

30.0

15.0

8.9

    

Liver cirrhosis

 Present

25 (23.6)

44.0

15.0

5.6

0.888 (0.517-1.526)

0.668

NA

NA

 Absent

81 (76.4)

38.3

21.9

12.1

    

Preoperative AFP

 > 9 ng/ml

28 (26.4)

39.3

33.3

20.8

0.889 (0.527-1.499)

0.658

NA

NA

 ≤ 9 ng/ml

78 (73.6)

39.7

15.2

6.7

    

Preoperative CA19-9

 > 35 U/ml

73 (68.9)

34.2

14.3

9.8

1.499 (0.897-2.504)

0.119

NA

NA

 ≤ 35 U/ml

33 (31.1)

51.5

33.3

13.0

    

Hepatectomy

 Minor

48 (45.3)

47.9

26.3

15.2

1.560 (0.975-2.494)

0.061

NA

NA

 Major

58 (54.7)

32.8

16.4

7.8

    

Tumor size

 > 5 cm

61 (57.5)

26.2

12.5

5.7

2.044 (1.258-3.321)

0.003

1.947 (1.177-3.219)

0.009

 ≤ 5 cm

45 (42.5)

57.8

32.4

19.4

    

Tumor number

 Single

89 (84.0)

43.8

23.7

13.2

1.752 (1.002-3.064)

0.046

NS

NS

 Multiple

17 (16.0)

17.6

5.9

0

    

Child-Pugh score

 A

100 (94.3)

41.0

21.8

11.5

2.698 (1.158-6.282)

0.017

3.067 (1.293-7.275)

0.011

 B

6 (5.7)

16.7

0

0

    

Histology

 Well or moderate

52 (49.1)

46.2

18.2

9.8

1.084 (0.689-1.706)

0.727

NA

NA

 Poor

54 (50.9)

33.3

22.4

11.6

    

Vascular invasion

 Present

28 (26.4)

35.7

12.0

4.3

1.286 (0.782-2.116)

0.321

NA

NA

 Absent

78 (73.6)

41.0

23.5

13.1

    

Lymph node metastasis

 Present

48 (45.3)

18.8

2.2

0

2.816 (1.747-4.538)

< 0.001

2.790 (1.628-4.781)

< 0.001

 Absent

58 (54.7)

56.9

37.5

22.5

    
  1. HR hazard ratio, CI confidence interval, NA not applicable, HBV hepatitis B virus, HBsAg hepatitis B surface antigen, HBcAb hepatitis B core antibody, AFP alpha fetoprotein, CA19-9 carbohydrate antigen 19-9, NS not significant